ArticleReumatologia2022

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients - the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response - results from the multicenter observational ACT-POL study.

Marcin Stajszczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.